Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.

Further Reading

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

5 Apr 2022
NIH program provides a real-time risk assessment of variants of SARS-CoV-2

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

31 Mar 2022
Therapeutic antibodies against filoviruses including Ebola and Marburg

Therapeutic antibodies against filoviruses including Ebola and Marburg

31 Mar 2022
Research provides a roadmap for new therapies to treat chorioamnionitis

Research provides a roadmap for new therapies to treat chorioamnionitis

30 Mar 2022
ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

30 Mar 2022
Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

29 Mar 2022
Northwestern scientists continue to advance the understanding of COVID-19

Northwestern scientists continue to advance the understanding of COVID-19

28 Mar 2022
Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

28 Mar 2022
Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

27 Mar 2022
Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

From Sino Biological Inc. 24 Mar 2022
Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers investigate Galectin-9 as a new treatment target for COVID-19

23 Mar 2022
Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

23 Mar 2022
Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

23 Mar 2022
CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

22 Mar 2022
Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

22 Mar 2022
Study reveals novel tumor biomarker of aggressive cancers with poor prognosis

Study reveals novel tumor biomarker of aggressive cancers with poor prognosis

22 Mar 2022
Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

18 Mar 2022
It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

17 Mar 2022
Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

16 Mar 2022
Do anti-nucleocapsid antibodies affect COVID-19 immune reactions?

Do anti-nucleocapsid antibodies affect COVID-19 immune reactions?

15 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback